PRME
Prime Medicine Inc

2,445
Mkt Cap
$684.14M
Volume
122.00
52W High
$6.94
52W Low
$1.11
PE Ratio
-2.52
PRME Fundamentals
Price
$3.72
Prev Close
$3.79
Open
$3.77
50D MA
$4.92
Beta
2.03
Avg. Volume
4.26M
EPS (Annual)
-$1.65
P/B
4.14
Rev/Employee
$13,939.25
Loading...
Loading...
News
all
press releases
Prime Medicine Target of Unusually High Options Trading (NYSE:PRME)
Prime Medicine, Inc. (NYSE:PRME - Get Free Report) saw some unusual options trading activity on Wednesday. Investors bought 5,892 call options on the stock. This represents an increase of...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Prime Medicine (NASDAQ:PRME) Shares Down 5.8% - What's Next?
Prime Medicine (NASDAQ:PRME) Shares Down 5.8% - Here's Why...
MarketBeat·7d ago
News Placeholder
Prime Medicine (NYSE:PRME) Trading Down 6.1% - Should You Sell?
Prime Medicine (NYSE:PRME) Stock Price Down 6.1% - Should You Sell...
MarketBeat·7d ago
News Placeholder
Prime Medicine (NASDAQ:PRME) Shares Up 7.7% - Should You Buy?
Prime Medicine (NASDAQ:PRME) Trading Up 7.7% - Here's Why...
MarketBeat·7d ago
News Placeholder
Prime Medicine (NYSE:PRME) Shares Up 9.1% - Here's What Happened
Prime Medicine (NYSE:PRME) Shares Up 9.1% - Should You Buy...
MarketBeat·7d ago
News Placeholder
FY2025 EPS Estimate for Prime Medicine Increased by Analyst
Prime Medicine, Inc. (NYSE:PRME - Free Report) - Stock analysts at HC Wainwright increased their FY2025 earnings estimates for Prime Medicine in a research note issued to investors on Thursday...
MarketBeat·9d ago
News Placeholder
FY2025 EPS Estimate for Prime Medicine Decreased by Analyst
Prime Medicine, Inc. (NYSE:PRME - Free Report) - Investment analysts at Chardan Capital reduced their FY2025 earnings estimates for shares of Prime Medicine in a note issued to investors on Monday...
MarketBeat·12d ago
News Placeholder
Chardan Capital Forecasts Prime Medicine FY2026 Earnings
Prime Medicine, Inc. (NYSE:PRME - Free Report) - Analysts at Chardan Capital issued their FY2026 earnings per share estimates for Prime Medicine in a research report issued to clients and investors...
MarketBeat·13d ago
News Placeholder
Prime Medicine (NYSE:PRME) Price Target Cut to $4.25 by Analysts at Citigroup
Citigroup lowered their price target on Prime Medicine from $5.00 to $4.25 and set a "neutral" rating on the stock in a research note on Tuesday...
MarketBeat·14d ago
News Placeholder
Prime Medicine (NASDAQ:PRME) Trading 7.1% Higher - Here's Why
Prime Medicine (NASDAQ:PRME) Stock Price Up 7.1% - What's Next...
MarketBeat·14d ago

Latest PRME News

View

Advertisement|Remove ads.

Advertisement|Remove ads.